Comparison Of Health Care Costs Between Rheumatoid Arthritis Patients Initiating First Or Second-Line Subcutaneous Abatacept, Adalimumab, Or Etancercept- A Difference-In-Difference Analysis
Abstract
Authors
S.S. Johnston D. McMorrow R. Fowler D. Smith A. Nadkarni